ATLASNovoCure (NVCR) earnings date: expected January 18–24
NovoCure (NVCR) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 18–24. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on NVCR
| Last price | $13.15 (+0.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.4% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 6 reports |
These figures come from the same calibrated model and valuation as the NovoCure stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 18–24 (estimate). One email the day before, with ATLAS’s read on NovoCure. You can switch it off at any time.
Alert me before NVCR reportsFree to start. Creating an account takes under a minute.
Notify me when NovoCure reports
NVCR earnings at a glance
| Next report | Not announced · expected around January 18–24 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Beat |
| Beat rate (last 6 reports) | 4 of 6 (67%) |
| Average EPS surprise | +12.9% |
| Average move around a report | ±13.7% (last 5) |
| Sector | Healthcare · Medical Devices |
The expected window is an ATLAS estimate: it takes the typical gap between NovoCure’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
NovoCure earnings history: last 6 reports
NovoCure last reported on Oct 29, 2026: EPS of -$0.09 against an estimate of -$0.21 (+57.1% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | -$0.21 | -$0.09 | +57.1% | Beat | – |
| Jul 23, 2026 | -$0.33 | -$0.13 | +60.6% | Beat | +13.4% |
| Jul 9, 2026 | $0.04 | -$0.02 | -150.0% | Miss | -6.2% |
| Apr 30, 2026 | -$0.51 | -$0.62 | -21.6% | Miss | +39.3% |
| Feb 26, 2026 | -$0.41 | -$0.22 | +46.3% | Beat | -8.8% |
| Dec 11, 2025 | -$2.13 | -$0.32 | +85.0% | Beat | +0.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for NVCR
See the fair value, the probability range and the earnings history of NovoCure on its ATLAS page.
NovoCure (NVCR) stock analysisPlans from €3.99 a month.
NovoCure earnings: frequently asked questions
When is NovoCure (NVCR) next earnings date?
NovoCure has not announced its next report. Its last 4 reports came Oct 29, 2026, Jul 23, 2026, Apr 30, 2026, Feb 26, 2026, so ATLAS estimates the next one around January 18–24. This is an estimate based on that pattern, not a confirmed date.
How often does NVCR beat earnings estimates?
Of its last 6 reports with a recorded result, NovoCure beat the EPS estimate 4 times; the average surprise was +12.9%. Past results do not predict the next one.
How much does NVCR move around earnings?
Over its last 5 reports the stock moved an average of 13.7% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did NovoCure beat earnings estimates last quarter?
NovoCure last reported on Oct 29, 2026: EPS of -$0.09 against an estimate of -$0.21 (+57.1% surprise), a beat.
How much does NVCR usually move in a day?
On a normal trading day the ATLAS model puts NVCR’s one-day range at about ±3.4%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer